CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- 4 Grant or award Senior Vice President, Finance acquired 30,600 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 9,375 shares (to pay taxes)
- 4 Planned sale Chief Medical Officer sold 879 shares at $18.40 ($16,174)
- 4 Grant or award Chief Operating Officer acquired 243.54 shares (grant or award)
- 4 Shares withheld for taxes Senior Vice President, Finance gave up 159 shares (to pay taxes)
- 4 Planned sale Chief Operating Officer sold 500 shares at $19.76 ($9,880)
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Operating Officer sold 500 shares at $12.86 ($6,430)
- 4 Open-market buy Director bought 1,512 shares at $13.25 ($20,034)
- 4 Open-market buy Director bought 1,000 shares at $12.81 ($12,810)
- 4 Open-market buy Director bought 2,000 shares at $12.90 ($25,800)
- 4 Open-market buy Chief Executive Officer bought 8,264 shares at $12.10 ($99,994)
- 4/A Open-market buy Director bought 3,400 shares at $12.01 ($40,834)
- 4 Open-market buy Director bought 1,400 shares at $11.58 ($16,212)
- 4 Open-market buy Director bought 3,400 shares at $12.01 ($40,834)
- 4 Planned sale Chief Medical Officer sold 945 shares at $20.05 ($18,947)
- 4 Grant or award Chief Operating Officer acquired 160.37 shares (grant or award)
- 4 Planned sale Chief Medical Officer sold 2,836 shares at $28.25 ($80,117)
Page 4 of 35 · 695 filings